Med Plus Inc is categorized under Internal Medicine Practitioners in Chicago, IL and active since 1998.
Med Plus Inc was established in 1998, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Practitioners business, which does work in the B2C market, and is classified as a Internal Medicine Practitioners, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact John Soldana, Office Manager at the company’s single location by writing to 8700 South Dante Avenue, Chicago, Illinois IL 60619 or by phoning (773) 221-3900. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Med Plus Inc |
Contact Person: | John Soldana, Office Manager |
Address: | 8700 South Dante Avenue, Chicago, Illinois 60619 |
Phone Number: | (773) 221-3900 |
Website Address: | medplus.com |
Annual Revenue (USD): | $500.000 to $999.999 |
Founded: | 1998 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Internal Medicine Practitioners |
SIC Code: | 8011 |
NAICS Code: | 6211110 |
Share This Business: |
Med Plus Inc was started in 1998 to provide professional Internal Medicine Practitioners under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact John Soldana, Office Manager for inquiries that concern Med Plus Inc by calling the company number (773) 221-3900, as your correspondence is most welcome. Additionally, the physical location of the single location of Med Plus Inc can be found at the coordinates 41.73672,-87.58942 as well as the street address 8700 South Dante Avenue in Chicago, Illinois 60619.
For its online presence, you may visit Med Plus Inc’s website at medplus.com and engage with its social media outlets through on Twitter and on Facebook.